Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Xenon Pharmaceuticals Inc. - Common Shares
(NQ:
XENE
)
63.53
-1.41 (-2.17%)
Streaming Delayed Price
Updated: 12:15 PM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
140,274
Open
65.32
Bid (Size)
63.46 (100)
Ask (Size)
63.60 (200)
Prev. Close
64.94
Today's Range
63.53 - 65.64
52wk Range
30.00 - 72.66
Shares Outstanding
63,562,303
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 29, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Performance
YTD
+42.8%
+42.8%
1 Month
+5.7%
+5.7%
3 Month
+16.5%
+16.5%
6 Month
+49.9%
+49.9%
1 Year
+105.1%
+105.1%
More News
Read More
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
↗
May 18, 2026
Via
The Motley Fool
Xenon Pharmaceuticals (NASDAQ:XENE) Reports Mixed Q1 Results as Azetukalner Nears FDA Submission
↗
May 07, 2026
Via
Chartmill
XENON PHARMACEUTICALS INC (NASDAQ:XENE) Breakout Setup Combines 9/10 Technical Strength with 9/10 Consolidation Quality
↗
May 02, 2026
Via
Chartmill
Xenon Pharmaceuticals Q1 Earnings Call Highlights
↗
May 09, 2026
Via
MarketBeat
Topics
Earnings
Xenon (XENE) Q1 2026 Earnings Transcript
↗
May 07, 2026
Via
The Motley Fool
Xenon Reports Q1 2026 Financial Results and Provides Business Update
May 07, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Report Q1 2026 Financial Results on May 7, 2026
April 30, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
April 19, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at Upcoming Investor Conferences
April 15, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
April 07, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
↗
March 27, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
March 12, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
March 12, 2026
Via
Finterra
Topics
ETFs
Intellectual Property
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
March 10, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE)
March 10, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
XENE Stock Rallies 50% On Epilepsy Trial Data, But One Analyst Thinks Rival Biohaven Still Has ‘Room To Differentiate’
↗
March 09, 2026
Via
Stocktwits
Xenon Pharmaceuticals Announces Proposed Public Offering
March 09, 2026
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Top stock movements in today's session.
↗
March 09, 2026
Via
Chartmill
Monday's session: top gainers and losers
↗
March 09, 2026
Via
Chartmill
Frequently Asked Questions
Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?
Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market
What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?
The current price of Xenon Pharmaceuticals Inc. - Common Shares is 63.53
When was Xenon Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 07/29/26 12:15 PM ET
What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?
The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 4.04B
How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?
Xenon Pharmaceuticals Inc. - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
